Liver transplant study aims to predict who recovers best

NCT ID NCT07414095

Recruiting now Knowledge-focused Sponsor: Izmir Bakircay University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how frailty, muscle loss, nutrition, and mental health affect people waiting for a liver transplant. Researchers will test physical strength, walking ability, and daily living skills, and also check nutrition and psychological well-being. The goal is to see which factors predict better or worse outcomes after transplant, such as hospital stay length and survival. The study includes 60 adults aged 18-65 who are on the liver transplant list and can understand Turkish.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors identify high-risk liver transplant candidates earlier and design better support programs to improve recovery and survival.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may not lead to immediate changes in patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure cirrhosis of liver End Stage Liver Disease Fibrosis Frailty Malnutrition Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS END STAGE LIVER DISEASE LIVER TRANSPLANTATION

Contacts and locations

Locations

Izmir University of Economics Medical Point Hospital
RECRUITING

Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.